Abstract Submissions

Present Your Research at the 2025 NORD Breakthrough Summit

Academics, researchers, industry, government agencies, healthcare professionals, patient organizations and students that have conducted rare disease or orphan product research studies or public health projects relevant in rare disease are invited to submit an abstract for inclusion in the 2025 NORD Breakthrough Summit Poster Hall.

Key Dates:
Submission deadline: July 18, 2025
NORD notifies authors of acceptance: August 18, 2025
Click here to download the Abstract Submission Guidelines.

"*" indicates required fields

Main Point of Contact

All correspondence with NORD, including decision notification, will be through the main point of contact unless noted below.
Main Point of Contact Name*

Abstract Author Details

* indicates required field
Presenting Author
Presenting Author's First Name*
Presenting Author's Last Name*
Presenting Author’s Degrees/Credentials*
Presenting Author's Company/Organization Name*
Presenting Author's Email Address*
 
Additional Authors (if applicable)

* indicates required field
Additional Author's Name (Last)*
Additional Author's Name (First Initial)*
Additional Author’s Degrees/Credentials*
Additional Author's Company/Organization Name*
Additional Author's Email*
 

Notifications

Please list the email address for each person other than the main point of contact who should receive notifications about this submission.

Attendance Details

In-person Display Agreement*
Registration Fee Agreement*

Submission of an abstract constitutes a commitment by the presenting author to present their work in the poster hall if the abstract is accepted. All additional abstract authors are encouraged to purchase a registration to attend the Summit. 

Please list authors, in addition to the Presenting Author, that will be attending the NORD Breakthrough Summit:
First Name
Last Name
 

Abstract Details

Abstract submissions are accepted in the areas of Innovative Research in Rare Diseases and Orphan Products, Medical Education Advancement in Rare Diseases and Orphan Products, Patient Community Building in Rare Diseases, and Other Topics.
The Word document should include title and abstract. Author names should not be included and entered above only.
Max. file size: 5 MB.

Figures and Tables

Upload up to 2 images / figures with title or caption. Uploads must be in jpg form.
Max. file size: 50 MB.
50 MB max
Max. file size: 50 MB.
50 MB max
Content Agreement*
Author(s) hereby represents and warrants that she/he/they is/are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, and that the work does not infringe upon any copyright, proprietary or personal right of any third party.

IMPORTANT

Prior to submitting your abstract, please read our abstract guidelines carefully. Submitted abstracts that do not comply with the guidelines and format will not be reviewed or considered for inclusion in the poster hall.

Questions: Please email [email protected]

This field is for validation purposes and should be left unchanged.